Seer Inc at Morgan Stanley Global Healthcare Conference Transcript
Hey, everyone. Welcome. I'm Tejas Savant. I'm the life science tools and diagnostics analyst here at Morgan Stanley. It's my pleasure to host Seer this morning, and from the company, we have Omid Farokhzad and David Horn, CEO and CFO. So thanks, gents, for joining us.
Before I kick it off with the Q&A, research disclosures, please see the Morgan Stanley website at morganstanley.com/researchdisclosures. And if you have any questions, do reach out to your sales rep.
Questions & Answers
Omid, thanks for doing this again. And maybe just to set the stage, clearly an exciting year for you guys following the commercial launch of the Proteograph. Can you just highlight what you view as your key accomplishments year-to-date? And what are you most excited about heading into '23?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |